CALCIFIED TISSUE INT 润色咨询

CALCIFIED TISSUE INTERNATIONAL

出版年份:1979 年文章数:2075 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2023-07-31 探宝者 来自江苏省

    审稿速度:24.0 | 投稿命中率:95.0
    经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2022-12-09 ms4000001525608322 来自江西省

    Reviewers Assigned会持续多久啊

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2021-12-28 rayms

    是否一定要按照结果的顺序撰写方法的顺序?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2021-12-27 衣谷

    什么叫实验室常规使用方法?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2020-03-20 147d8c05m87(暂无昵称)

    版面费多少V587-Ivy 2020-01-27 00:00:00 发表:
    关于AS哪方面的方便说一下吗?

    V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2020-01-27 V587-Ivy

    关于AS哪方面的方便说一下吗?啾啾啾喵喵 2019-03-16 08:42:00 发表:
    2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。

    啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2019-03-16 啾啾啾喵喵

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2019-01-11 ms7933220824164544

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2018-12-07 Jctcm

    请问这个杂志是否收综述?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2150692, encodeId=6b16215069227, content=审稿速度:24.0 | 投稿命中率:95.0<br>经验分享:很垃圾的杂志,投稿半个月分配编辑,半个月后还是邀请编辑中,实在是等不了了,就发了一个邮件问一下情况,然后立刻就把稿件拒绝了,说不符合期刊要求。我就想请问你,不符合要求,你需要拖一个月么,作者发邮件咨询一下,就立刻退稿?不靠谱的杂志,永远凌驾于作者之上!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Mon Jul 31 22:48:47 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2105144, encodeId=932321051442c, content=Reviewers Assigned会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b748176405, createdName=ms4000001525608322, createdTime=Fri Dec 09 21:52:09 CST 2022, time=2022-12-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1088285, encodeId=6d881088285f0, content=是否一定要按照结果的顺序撰写方法的顺序?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088286, encodeId=0656108828672, content=什么叫实验室常规使用方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587062, encodeId=801758e062f9, content=版面费多少<span class="quote">V587-Ivy 2020-01-27 00:00:00 发表:<br>关于AS哪方面的方便说一下吗?</span>, beContent=V587-Ivy 2020-01-27 00:00:00 发表: 关于AS哪方面的方便说一下吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bf5248958, createdName=147d8c05m87(暂无昵称), createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583877, encodeId=bbcf5838e7fe, content=关于AS哪方面的方便说一下吗?<span class="quote">啾啾啾喵喵 2019-03-16 08:42:00 发表:<br>2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。</span>, beContent=啾啾啾喵喵 2019-03-16 08:42:00 发表: 2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Mon Jan 27 00:00:00 CST 2020, time=2020-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568171, encodeId=1a8c5681e1df, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:2018年12月20号投稿,1月28号修改意见回来,大修,2月20修回,3.13接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Sat Mar 16 08:42:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849195, encodeId=b0f08491955c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这个期刊越办越好了,最近几年的分一直在涨就是比较好的证明,最近投了两篇,审稿人给的意见非常好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Fri Jan 11 17:11:47 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564134, encodeId=54c65641347b, content=请问这个杂志是否收综述?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=522a1620479, createdName=Jctcm, createdTime=Fri Dec 07 06:12:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558347, encodeId=ca2455834e47, content=请问这个杂志是否需要提供原始数据?<span class="quote">medcardio 2015-03-01 13:03:00 发表:<br>同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!</span>, beContent=medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f802275553, createdName=121b44f1m87(暂无昵称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]
    2018-06-26 121b44f1m87(暂无昵称)

    请问这个杂志是否需要提供原始数据?medcardio 2015-03-01 13:03:00 发表:
    同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!

    medcardio 2015-03-01 13:03:00 发表: 同意这位意见!骨松类好发. 2012年中国人发了3篇.2013年4篇.2014年上升到12篇.很快!

    0

共23条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分